⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27390994 | 0.92 | POLB (0.31) | — | |
| SCHEMBL31695277 | 0.92 | ABCB1 (0.30) | — | |
| SCHEMBL24630168 | 0.92 | ABCB1 (0.30) | — | |
| SCHEMBL29326702 | 0.86 | — | — | |
| SCHEMBL24630222 | 0.86 | — | — | |
| SCHEMBL24630325 | 0.86 | — | — | |
| SCHEMBL31695118 | 0.85 | LMNA (0.31) | — | |
| SCHEMBL24630324 | 0.83 | NANP (0.35) | — | |
| SCHEMBL27391407 | 0.83 | — | — | |
| SCHEMBL31225294 | 0.81 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240238422-A1 | Hypoimmunogenic Biotherapeutics | ADAXION THERAPEUTICS, INC. | 2024-07-18 | — | — | US | disclosed |
| US-20240238422-A1 | Hypoimmunogenic Biotherapeutics | ADAXION THERAPEUTICS, INC. | 2024-07-18 | — | — | US | disclosed |